Biocon provides Q2 FY27 earnings call recording

Investor Communications View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.4%Reaction day

₹343.65

prior close

₹352.00

announcement price

After-mkt

timing

Nifty Midcap 150marketpendingvs market: pending

Pharmaceuticals peers, median of 171sector+0.5%+4.9% vs sector

On the reaction day the stock moved 4.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.7

10m

-0.0

15m

-0.3

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.4pendingpending+0.5+4.9

Next day

+6.2pendingpending+0.4+5.8

—————

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 171Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biocon Limited has filed links to the audio and video recording of its Q2 FY27 earnings call held on November 4, 2026. The filing only provides access to the recording on the company website and contains no financial results, guidance, targets, or other call details.

Likely market impact

No new financial information is disclosed in the filing. Shareholders should review the earnings call recording for business updates.